USPTO Issues 1st Parthenogenetic Stem Cell Patent

Law360, New York (June 9, 2010, 11:59 AM EDT) -- The first-ever patent for developing stem cells without creating or destroying a human embryo has been approved and issued to the International Stem Cell Corp., which could provide a way to avoid the ethical controversy associated with stem cell research.

U.S. Patent Number 7,732,202, issued Tuesday by the U.S. Patent and Trademark Office, covers a method of inducing an unfertilized egg to create cells as it would in pregnancy, allowing researchers to derive the same pluripotent cells used in embryonic stem cell research to potentially produce...
To view the full article, register now.